Sakana AI’s TMLR paper introduces Multi-Layered Review, a 3-agent Claude-based reviewer, and a 1,164-error Contradiction ...

Code, data and models for "Do Language Models Know What Compelling Scientific Evidence Looks Like?" . Ibis0 models read a biological hypothesis together with a set of experimental ...

The model excels at complex coding, financial analysis, 3D creation, and software-security work, showing particularly large ...

"Claude Opus 5.5 and GPT-6 Astra are certainly smart, but if you run them hard for long coding sessions or agent tasks, the ...

Spend long enough on fitness social media and you’ll see the same tip. Finish every weight training session with about 15 minutes of cardio to boost your “gains”. But does it actually work? Probably ...

Strength training isn’t just for muscle and bone health — it’s also surprisingly good cardio. By Hilary Achauer This article is part of our Longevity special section on living longer and healthier.

A few weeks ago, I stepped on the scale and saw that my weight had gone down. My younger self would have looked at that number, and it would have set the tone for a good-mood kind of day. She would ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The metabolic benefits of strength training may begin long before ...

Just seven days of strength training increased visceral fat burning in obese mice, even before any weight loss could be seen on a scale. In an experiment conducted at the State University of Campinas ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Agility Robotics is launching Digit 5, a next-generation humanoid robot designed for safe, ...

Calisthenics has gained enormous popularity in recent years, particularly thanks to social media and the rise of workout areas in city parks. You probably know some of the moves already, like pull-ups ...

Novo Nordisk was first with a GLP-1 weight-loss shot, but lost the lead to Eli Lilly. Novo Nordisk was first to market with a GLP-1 pill, though Eli Lilly is now competing there, as well. Novo Nordisk ...